卡雷特拉、利巴韦林和索非布韦3种抗病毒方案治疗COVID - 19的疗效比较

Autoimmune and Infectious Diseases: Open Access Pub Date : 2020-01-01 DOI:10.16966/2470-1025.129

Davoudi A, Najafi N, Sphandyari E, Kasgari Ha, Tayebi A, Akbari A, Tabarestani M, Beyzaee Am

{"title":"卡雷特拉、利巴韦林和索非布韦3种抗病毒方案治疗COVID - 19的疗效比较","authors":"Davoudi A, Najafi N, Sphandyari E, Kasgari Ha, Tayebi A, Akbari A, Tabarestani M, Beyzaee Am","doi":"10.16966/2470-1025.129","DOIUrl":null,"url":null,"abstract":"Background: New therapeutic options are urgently needed to handle the ongoing pandemic of coronavirus disease 2019 (COVID-19). As some antiviral therapeutic regimens are assumed to be helpful, we decided to compare the efficacy of kaletra, kaletra plus ribavirin, and kaletra plus ribavirin plus sofosbuvir, as three different therapeutic regimens in covid 19 patients.","PeriodicalId":8657,"journal":{"name":"Autoimmune and Infectious Diseases: Open Access","volume":"26 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of the Efficacy of 3 Anti-Viral Regimens Containing Kaletra, Ribavirin and Sofosbuvir in COVID 19 Disease\",\"authors\":\"Davoudi A, Najafi N, Sphandyari E, Kasgari Ha, Tayebi A, Akbari A, Tabarestani M, Beyzaee Am\",\"doi\":\"10.16966/2470-1025.129\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: New therapeutic options are urgently needed to handle the ongoing pandemic of coronavirus disease 2019 (COVID-19). As some antiviral therapeutic regimens are assumed to be helpful, we decided to compare the efficacy of kaletra, kaletra plus ribavirin, and kaletra plus ribavirin plus sofosbuvir, as three different therapeutic regimens in covid 19 patients.\",\"PeriodicalId\":8657,\"journal\":{\"name\":\"Autoimmune and Infectious Diseases: Open Access\",\"volume\":\"26 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Autoimmune and Infectious Diseases: Open Access\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.16966/2470-1025.129\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autoimmune and Infectious Diseases: Open Access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.16966/2470-1025.129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

背景:为应对持续不断的2019冠状病毒病(COVID-19)大流行，迫切需要新的治疗方案。由于一些抗病毒治疗方案被认为是有帮助的，我们决定比较卡列妥拉、卡列妥拉加利巴韦林、卡列妥拉加利巴韦林加索非布韦作为三种不同治疗方案在covid - 19患者中的疗效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Comparison of the Efficacy of 3 Anti-Viral Regimens Containing Kaletra, Ribavirin and Sofosbuvir in COVID 19 Disease

Background: New therapeutic options are urgently needed to handle the ongoing pandemic of coronavirus disease 2019 (COVID-19). As some antiviral therapeutic regimens are assumed to be helpful, we decided to compare the efficacy of kaletra, kaletra plus ribavirin, and kaletra plus ribavirin plus sofosbuvir, as three different therapeutic regimens in covid 19 patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Autoimmune and Infectious Diseases: Open Access

自引率

0.00%

发文量